Paugh et al. (2016) reported that decreased methylation of the Caspase-1 promoter results in increased transcription and activation of NLRP3 and Caspase1, which cleaves the glucocorticoid receptors used in the treatment of ALL, what suggests their association with relapse episodes10, 39. Here, NR3C1 is linked to acute lymphoblastic leukemia.